Booming antibodies 2001
MasterControl - Learn How to Avoid Obstacles in Pharma Manufacturing
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

PerkinElmer Expands Genomic Testing Services with Ultrarapid Whole Genome Sequencing

Tuesday, May 17, 2022

PerkinElmer Inc a global leader committed to innovating for a healthier world today announced the availability of ultrarapid whole genome sequencing urWGS through PerkinElmer Genomics This addition to the Companys portfolio of whole genome sequencing...

Proteros Expands Oncology Collaboration and License Agreement with AstraZeneca

Tuesday, May 17, 2022

Proteros biostructures GmbH an expert in integrated structurebased drug discovery announces today an expansion of its collaboration with AstraZeneca focused on the discovery and development of novel epigenetic drugs The new multiyear agreement builds...

Inmagene Receives FDA IND Clearance for a Third Generation BTK Inhibitor Targeting Immunological Diseases

Monday, May 16, 2022

Inmagene Biopharmaceuticals announces that today the US Food and Drug Administration FDA cleared its investigational new drug IND application for the drug candidate IMG a noncovalent reversible thirdgeneration Bruton Tyrosine Kinase BTK inhibitor to...

Neurocrine Biosciences Receives Orphan Drug Designation for Valbenazine as a Treatment for Chorea Associated with Huntington Disease

Friday, May 13, 2022

Neurocrine Biosciences Inc announced that it has received Orphan Drug Designation from the US Food and Drug Administration FDA for valbenazine as a treatment for Huntington disease HD The treatment of chorea associated with HD is within the scope of...

Mindset Pharma Progresses Plans for Clinical Trials of its Advanced Pre-Clinical Psychedelic, MSP-1014

Friday, May 13, 2022

Mindset Pharma Inc a drug discovery and development company focused on creating optimized and patentable nextgeneration psychedelic medicines to treat neurological and psychiatric disorders with unmet medical needs today announced that it is making h...

Nuvig Launches to Develop Novel Immune Therapeutics for Chronic Inflammatory and Autoimmune Diseases

Thursday, May 12, 2022

Nuvig Therapeutics Inc announced today the launch of the company to develop novel therapeutics that induce mechanisms of immune homeostasis and treat autoimmune diseases without compromising normal immune function To support this mission the company...

Neuvivo Begins Manufacturing of NP001 for Treatment of ALS

Thursday, May 12, 2022

Neuvivo a biopharmaceutical company dedicated to delivering an effective safe ALS treatment to patients today announced that it has initiated cGMP manufacturing of NP for the treatment of ALS Lou Gehrigs Disease The company expects to have product a...

Pfizer to Acquire Biohaven Pharmaceuticals

Wednesday, May 11, 2022

Pfizer Inc and Biohaven Pharmaceutical Holding Company Ltd announced that the companies have entered into a definitive agreement under which Pfizer will acquire Biohaven the maker of NURTEC ODT an innovative dualacting migraine therapy approved for b...

Thermo Fisher Scientific Introduces QualTrak Biopharma qPCR Solutions to Streamline Biologics Development and Compliance

Wednesday, May 11, 2022

Thermo Fisher Scientific today launched a new collection of qPCR biopharma offerings to help accelerate drug development to meet a growing demand for novel biologics The QualTrak comprehensive suite of qPCR tools is comprised of a premium selection o...

OPKO Health Acquires ModeX Therapeutics, Gains Proprietary Immunotherapy Technology with a Focus on Oncology and Infectious Diseases

Tuesday, May 10, 2022

OPKO Health Inc a multinational biopharmaceutical and diagnostics company today announced the acquisition of ModeX Therapeutics Inc a privately held biotechnology company focused on developing innovative multispecific immune therapies for cancer and...

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEA Bora Pharmaceuticals - CMDO making success Medical Fair Asia 2022 Medical Manufacturing Asia 2022